Smile Invest and Rabo Corporate Investment’s Acquisition of IGS GeboJagema

Loyens & Loeff advised Nordian Capital on the deal.

Nordian Capital completed the sale of IGS GeboJagema, a market leading company in hightech medical moulds, to Smile Invest and minority investor Rabo Corporate Investments. The transaction is subject to the completion of customary regulatory approvals.

The Loyens & Loeff team included Harmen Holtrop (Photo), Michiel Rank, Freek Hilberdink, Marc Wiggers, Robert Fröger, Gianluca Kreuze, Anke van Holthe tot Echten.

Involved fees earner: Robert Fröger – Loyens & Loeff; Freek Hilberdink – Loyens & Loeff; Harmen Holtrop – Loyens & Loeff; Gianluca Kreuze – Loyens & Loeff; Michiel Rank – Loyens & Loeff; Anke van Holthe tot Echten – Loyens & Loeff; Marc Wiggers – Loyens & Loeff;

Law Firms: Loyens & Loeff;

Clients: Nordian Capital;

Author: Federica Tiefenthaler